For example, curcumin, a bioactive ingredient of the plant Curcuma longa, exerts an inhibitory effect on triple-negative MDA-MB-231 breast cancer cells through upregulation of p21 protein expression and enhancement of the Bax-to-Bcl-2 ratio [33,34]. This evidence concerns the gene BCL2 and breast carcinoma.